Task: Answer the multiple-choice question.
Question: Which drug exhibits a 12.373\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cc1ccc(-n2c(SCC(=O)Nc3ncc(Cl)cc3Cl)nc3ccccc32)cc1
b C=CCNC(=S)N(CC=C)C1CCS(=O)(=O)C1
c C1=C(N2CCOCC2)/C(=C/c2nc3ccccc3[nH]2)CC1
d CCCCn1nc(C(=O)Nc2nc3c(s2)CCCC3)c2ccccc2c1=O
Answer: c. C1=C(N2CCOCC2)/C(=C/c2nc3ccccc3[nH]2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C1=C(N2CCOCC2)/C(=C/c2nc3ccccc3[nH]2)CC1
C1=C(N2CCOCC2)/C(=C/c2nc3ccccc3[nH]2)CC1
4-[(5E)-5-(1H-benzimidazol-2-ylmethylidene)cyclopenten-1-yl]morpholine